Page last updated: 2024-10-26

etodolac and Cerebrovascular Disorders

etodolac has been researched along with Cerebrovascular Disorders in 1 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research Excerpts

ExcerptRelevanceReference
"A 28-year-old woman had thunderclap headache (TCH), after 7 days she had left hemiparesis."1.35Reversible cerebral vasoconstriction syndrome: case report. ( Bek, S; Demirkaya, S; Eroğlu, E; Odabaşi, Z; Oz, O; Ulaş, UH, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oz, O1
Demirkaya, S1
Bek, S1
Eroğlu, E1
Ulaş, UH1
Odabaşi, Z1

Other Studies

1 other study available for etodolac and Cerebrovascular Disorders

ArticleYear
Reversible cerebral vasoconstriction syndrome: case report.
    The journal of headache and pain, 2009, Volume: 10, Issue:4

    Topics: Adult; Angiography, Digital Subtraction; Anti-Inflammatory Agents, Non-Steroidal; Brain Infarction;

2009